Inayat U Rahman, Muhammad Idrees, Mohammad Bashir, Mohammad Iqbal Khan, Naeem Ullah Jan, Haroon Rahim.
Liraglutide in diabetes mellitus: More facts and findings..
Pak J Pharm Sci Jan ;29(2):609-13.

Liraglutide exert favorable effects on most of the diabetes associated cardiovascular (CV) risk factors and this study was designed to further explore the benefits of liraglutide by observing its effect on plasma sialic acid (PSA) in diabetic rats. A total of 30 streptozotocin induced (50 mg/Kg; i.p.) diabetic rats were randomized into vehicle treated (1 ml/Kg s.c, twice daily) group I, liraglutide treated groups II and III (30 mug/Kg and 150 mug/Kg, twice daily respectively) and studied for 6 weeks. Liraglutide treated groups showed significant reductions in fructosamine levels (p

PakMediNet -Pakistan's largest Database of Pakistani Medical Journals - http://www.pakmedinet.com